Stay updated on Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial page.

Latest updates to the Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial page
- CheckyesterdayChange DetectedA new Revision: v3.6.5 tag appears in the page footer, replacing Revision: v3.6.4. This reflects a version update of the page/interface rather than a modification to the study details or user-visible content.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing the previous v3.6.3. This indicates a small behind-the-scenes update to the page template or rendering.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedRevision number updated from v3.6.2 to v3.6.3. This reflects a minor update to the page's metadata and documentation rather than any changes to study data or user-facing content.SummaryDifference0.1%

- Check44 days agoChange DetectedFooter revision label changed from v3.6.0 to v3.6.2, representing a small page update without altering study details.SummaryDifference0.1%

- Check58 days agoChange DetectedRecruitment status updated to No longer looking for participants, indicating no new enrollments. New help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, and the revision note moved from v3.5.5 to v3.6.0 with a formatting change for Intervention/Treatment.SummaryDifference0.5%

- Check65 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5. This reflects a small page update and does not modify the study data or how the page functions.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial page.